Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This dual-peptide blend combines two research bioactive sequences: BPC-157, a gastric-derived synthetic peptide fragment, and TB-500 (Thymosin Beta-4 fragment), a stabilized actin-binding regulator analogue
Experimental mice got injections of the peptide 5 times a week, and the results showed that it suppressed the formation of neoplasms, decreased lungs metastases by 1,6 times, multiple tumors by 2 times, 3,7-fold increase of mice without breast tumors and decrease of mice with 6 or more tumors by 3 times
Madonna Grehan grew up in Brisbane in the 1970s and '80s and returns often to visit family
It is the wholesale substitution of consumer enthusiasm for clinical evidence
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
